Sustainability is deep rooted in all our decision making
We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
News Updates
5 JUNE 2024
Pharmaniaga Berhad (Pharmaniaga) will continue to leverage on improving operational efficiency and stringent cost control measures that has proven to have helped the Group to be resilient and re-emerged stronger amidst its challenging financial situation.
27 MAY 2024
Pharmaniaga Berhad (Pharmaniaga) today announces a strong performance in its first quarter ended 31 March 2024 (Q1 FY2024) with Profit After Zakat and Taxation (PAT) surged almost tenfold to RM26.2 million, up from RM2.8 million in the same quarter last year, signalling a robust financial recovery.
10 MAY 2024
Pharmaniaga Berhad (Pharmaniaga) stands firm with its commitment to financial recovery amidst the opinion of its independent auditor PricewaterhouseCoopers (PWC) on the Group’s 2023 financial statement, dated 29 March 2024.
29 FEBRUARY 2024
Pharmaniaga Berhad (Pharmaniaga) today announces the appointment of Zulkifli Jafar as its Executive Director, marking a pivotal move to navigate the turnaround of the Group, after the successful submission of Regularisation Plan to Bursa Malaysia within the stipulated timeline.
23 FEBRUARY 2024
Pharmaniaga Berhad announced today its significant step towards financial revitalisation by submitting the Regularisation Plan to Bursa Malaysia. This move marks a critical milestone by the Group to recover and enhance its financial standing, aiming to exit its Practice Note 17 (PN17) status.
29 NOVEMBER 2023
Pharmaniaga Berhad’s (Pharmaniaga) announces its plan to raise up to RM655 million to
bolster its financial position and revitalise financial health, marking a crucial step toward
exiting its Practice Note 17 (PN17) status.